C-aryl glucoside SGLT2 inhibitors and method

Details C-aryl glucoside SGLT2 inhibitors and method C-aryl glucoside SGLT2 inhibitors and method

2005-08-30

2005-08-30

Hui, San-Ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

06936590

ABSTRACT:
A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formulaalone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).

REFERENCES:
patent: 5444050 (1995-08-01), Kogan et al.
patent: 6414126 (2002-07-01), Ellsworth et al.
patent: 6515117 (2003-02-01), Ellsworth et al.
patent: 3632536 (1986-09-01), None
patent: 0 598359 (1994-05-01), None
patent: 0 684 254 (1995-11-01), None
patent: 0 773 226 (1997-05-01), None
patent: 0 850 948 (1998-01-01), None
patent: 0 997472 (2000-05-01), None
patent: 9124684 (1995-11-01), None
patent: 9124685 (1995-11-01), None
patent: 8-27006 (1996-01-01), None
patent: 9188625 (1996-11-01), None
patent: 10245391 (1997-03-01), None
patent: WO 01/16147 (2001-03-01), None
patent: WO 97/01335 (1997-01-01), None
patent: WO 9831697 (1998-07-01), None
patent: WO 0 018918 (2000-04-01), None
T. Kuribayashi et al., Journal of Carbohydrate Chemistry, (1999) vol. 18, No. 4, pp. 371-382.
W. Gaffield et al., Tetrahedron, (1978) vol. 34, No. 20, pp. 3089-3096.
Benhaddou et al. Carbohydrate Research 260 (1994) pp. 243-250.
Hongu et al. Chemical Phar. Bull. (1998) vol. 46, No. 10, pp. 1545-1555.
Tsujihara et al. Chemical Pharm. Bull. (1996) vol. 44. No. 6. pp. 1174-1180.
Hongu et al. Chem. Pharm. Bull. (1998) vol. 46. No. 1, pp. 22-23.
Oku et al. Diabetes. vol. 48 (1999) pp. 1794-1800.

Affiliated with

Also associated with

Rating

C-aryl glucoside SGLT2 inhibitors and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-aryl glucoside SGLT2 inhibitors and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-aryl glucoside SGLT2 inhibitors and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3468017